Skip to main content

Research Repository

Advanced Search

Practicality, Validity, and Responsiveness of Using the Proxy Version of the Child Health Utility–9 Dimensions With Children Aged 2 to 5 Years

Sach, Tracey H.; Williams, Hywel C.; Allen, Hilary; Boyle, Robert; Kelleher, Maeve; Brown, Sara; Cork, Mike; Flohr, Carsten; Jay, Nicola; Lartey, Stella; Davies, Charlotte; Lawton, Sandra; Perkin, Michael; Ridd, Matthew; Brooks, Joanne; Tarr, Stella; Wyatt, Laura; Thomas, Kim

Practicality, Validity, and Responsiveness of Using the Proxy Version of the Child Health Utility–9 Dimensions With Children Aged 2 to 5 Years Thumbnail


Authors

Tracey H. Sach

Hilary Allen

Robert Boyle

Maeve Kelleher

Sara Brown

Mike Cork

Carsten Flohr

Nicola Jay

Stella Lartey

Charlotte Davies

Sandra Lawton

Michael Perkin

Matthew Ridd

Joanne Brooks

Stella Tarr



Abstract


Objectives
To assess the practicality, validity and responsiveness of proxy CHU-9D in children aged 2-5 years.

Methods
We used data from BEEP, a UK randomised controlled trial testing whether daily emollients in infancy could prevent eczema in high-risk infants. The main parent/carer completed the proxy CHU-9D using developers’ additional guidance for completion in under-5’s and the Patient-Orientated Eczema Measure (POEM) at ages 2, 3, 4 and 5. Practicality was assessed by completion rates. Construct validity assessed if CHU-9D could discriminate between those with/without eczema and between eczema severity levels on POEM. Responsiveness was determined by ability to discriminate between three groups: those whose POEM score, i) deteriorated ≥3 points, ii) change not clinically important (-2.9 to 2.9 points), and iii) improved ≥3 points. Analysis was conducted in STATA 17.

Results
Of 1,394 children participating in BEEP, study questionnaires were completed by 1,212 (87%), 981 (70%), 990 (71%), and 976 (70%) at 2, 3, 4 and 5-years. Of these the CHU-9D was completed by 1,066 (88.0%), 685 (69.8%), 925 (93.4%) and 923 (94.6%) respectively. Mean utility at all timepoints was around 0.934 (range 0.443-1). For construct validity, very small differences on the CHU-9D between known groups were observed(p <0.01). 801 participants had responsiveness data: 13% deteriorated, 72% had non-clinically important change, and 15% improved. Mean utility change (standardised response mean) for these groups was -0.0198 (0.21), 0.0041 (0.05), and 0.0175 (0.21)showing small change and small responsiveness.

Conclusions
Proxy CHU-9D in 2-5 year old children shows potential but further research is needed.

Citation

Sach, T. H., Williams, H. C., Allen, H., Boyle, R., Kelleher, M., Brown, S., Cork, M., Flohr, C., Jay, N., Lartey, S., Davies, C., Lawton, S., Perkin, M., Ridd, M., Brooks, J., Tarr, S., Wyatt, L., & Thomas, K. (2024). Practicality, Validity, and Responsiveness of Using the Proxy Version of the Child Health Utility–9 Dimensions With Children Aged 2 to 5 Years. Value in Health, https://doi.org/10.1016/j.jval.2024.08.010

Journal Article Type Article
Acceptance Date Aug 19, 2024
Online Publication Date Oct 9, 2024
Publication Date 2024-10
Deposit Date Nov 5, 2024
Publicly Available Date Nov 7, 2024
Journal Value in Health
Print ISSN 1098-3015
Electronic ISSN 1524-4733
Publisher Elsevier
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1016/j.jval.2024.08.010
Public URL https://nottingham-repository.worktribe.com/output/40590175
Publisher URL https://www.valueinhealthjournal.com/article/S1098-3015(24)02861-4/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301524028614%3Fshowall%3Dtrue

Files

Practicality Validity And Responsiveness Of Using The Proxy Version Of The Child Health Utility-9 Dimensions With Children Aged 2 To 5 Years (470 Kb)
PDF

Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/

Copyright Statement
© 2024 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.
User License: Creative Commons Attribution (CC BY 4.0)





You might also like



Downloadable Citations